Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Teen girls' beliefs regarding HPV vaccine not linked to subsequent sexual behaviors

A new study may alleviate concerns that the human papillomavirus (HPV) vaccine leads to either the initiation of sex or unsafe sexual behaviors among teenage girls and young women.

3 Feb 2014

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease.

30 Jan 2014

Vaccine to treat precancerous cervical lesions triggers immune cell response

Preliminary results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself.

30 Jan 2014

Researchers identify therapeutic target for cervix cancer

Gene related to the proliferation of cancerous cells blocked through molecular technology. A group of researchers from Mexico's General Hospital, Health Secretariat, Medicine Faculty and the Institute of Cellular Physiology of the National Autonomous University of Mexico (UNAM) identified a therapeutic target for cervix cancer: gene CDKN3.

28 Jan 2014

Researchers examine effects of ACA on cancer survivors

In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.

24 Jan 2014

Use of twice-daily pill could turn deadly blood cancer into highly treatable disease

Use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease, according to scientists at Weill Cornell Medical College who led a multinational research team.

24 Jan 2014

OBGYN.net to present new research and topics related to cervical health

UBM Medica US announces that OBGYN.net, a leading online community for medical professionals specializing in women's health, will present new research and topics over the coming weeks related to cervical cancer and cervical health in honor of January being Cervical Health Awareness Month.

23 Jan 2014

Study identify key barriers associated with lack of cancer screenings in Appalachian women

A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.

23 Jan 2014

Self-testing for HPV effective in detecting cervical cancer

Self-testing for Human Papillomavirus (HPV) - the virus that causes cervical cancer - is as effective at detecting cancer as a conventional smear test (cytology screening) even when scaled up to test large populations.

22 Jan 2014

Study provides insight into physician recommendations to improve HPV vaccination

The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

Testing for HPV allows for longer time between screening tests

A new study from Karolinska Institutet in Sweden finds that testing for human papilloma virus (HPV) allows for longer time between screening tests when compared to cytology-based testing. The study is published in the scientific journal British Medical Journal (BMJ).

21 Jan 2014

FTM transgender patients are more likely to have inadequate Pap tests

A new study finds that female-to-male (FTM) transgender patients had over 10 times higher odds of having an inadequate Papanicolaou (Pap) test compared to female patients.

16 Jan 2014

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

16 Jan 2014

Call for long follow-up after CIN3 treatment

Researchers from Sweden say that women who have been treated for cervical precancer should receive lifelong follow-up, after finding that their risk for dying from vaginal or cervical cancer markedly increases after the age of 60 years.

15 Jan 2014

Study highlights the importance of screening women over 50 for cervical cancer

New research from Queen Mary University of London reveals women over the age of 50 who don't attend cervical screening are four times more likely to be diagnosed with cervical cancer in later life.

15 Jan 2014

Lifestyle changes and screening tools prove to reduce cancer risk, says doctor

President Nixon funded research to wage a war on cancer, a long battle that we're still fighting today. While the last 40 years haven't brought us a cure, we have made some meaningful progress in developing tools and knowledge to take a bite out of our cancer risk.

10 Jan 2014

Weill Cornell Medical College received a $75M grant to expand, enhance cancer research, care programs

Weill Cornell Medical College announced today that it has received a $75 million gift from Sandra and Edward Meyer and the Sandra and Edward Meyer Foundation to expand and enhance the medical college's distinguished cancer research and care programs.

9 Jan 2014

Plasma thermogram can serve as an indicator of cervical cancer

Researchers at the University of Louisville have confirmed that using the heat profile from a person's blood, called a plasma thermogram, can serve as an indicator for the presence or absence of cervical cancer, including the stage of cancer.

8 Jan 2014

New study by bioethicists indicates patients give "broad endorsement" to iPSC research

In an early indication of lay opinions on research with induced pluripotent stem cells, which are stem cells made from skin or other tissues, a new study by bioethicists at Johns Hopkins University indicates that despite some ethical concerns, patients give the research "broad endorsement".

6 Jan 2014

Cervical Cancer News and Research

Further Reading

Teen girls' beliefs regarding HPV vaccine not linked to subsequent sexual behaviors

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Vaccine to treat precancerous cervical lesions triggers immune cell response

Researchers identify therapeutic target for cervix cancer

Researchers examine effects of ACA on cancer survivors

Use of twice-daily pill could turn deadly blood cancer into highly treatable disease

OBGYN.net to present new research and topics related to cervical health

Study identify key barriers associated with lack of cancer screenings in Appalachian women

Self-testing for HPV effective in detecting cervical cancer

Study provides insight into physician recommendations to improve HPV vaccination

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Testing for HPV allows for longer time between screening tests

FTM transgender patients are more likely to have inadequate Pap tests

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

Call for long follow-up after CIN3 treatment

Study highlights the importance of screening women over 50 for cervical cancer

Lifestyle changes and screening tools prove to reduce cancer risk, says doctor

Weill Cornell Medical College received a $75M grant to expand, enhance cancer research, care programs

Plasma thermogram can serve as an indicator of cervical cancer

New study by bioethicists indicates patients give "broad endorsement" to iPSC research

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News